Clinical trial
The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients
NCT03260049 is registered in ClinicalTrials.gov with Chongqing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Necessity and Optimal Time for Performing Pars Plana Vitrectomy in Acute Retinal Necrosis Patients
- Lead sponsor
- Chongqing Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2012
- Completion date
- February 28, 2017
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute retinal necrosis